Pharmacodynamics Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting pharmacodynamics clinical trials across 5 countries. Studies span Phase 1, Phase 2, Phase 3. Top locations include Baltimore, Maryland, United States, Chula Vista, California, United States, Ann Arbor, Michigan, United States. Updated daily from ClinicalTrials.gov.


Pharmacodynamics Trials at a Glance

8 actively recruiting trials for pharmacodynamics are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Baltimore, Chula Vista, and Ann Arbor. Lead sponsors running pharmacodynamics studies include Johns Hopkins University, Children's Hospital of Fudan University, and Basking Biosciences, Inc..

Browse pharmacodynamics trials by phase

About Pharmacodynamics Clinical Trials

Looking for clinical trials for Pharmacodynamics? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pharmacodynamics trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pharmacodynamics clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients

SarcopeniaFrailtyNeuromuscular Blockade+2 more
Konya Meram State Hospital100 enrolled1 locationNCT07580144
Recruiting
Phase 2Phase 3

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting

Direct Observation Study of Kratom Product Effects Among Regular Consumers

Kratom PharmacokineticsKratom PharmacodynamicsKratom
Johns Hopkins University22 enrolled1 locationNCT06089980
Recruiting
Phase 1

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Healthy VolunteersPharmacokineticsPharmacodynamics
Basking Biosciences, Inc.72 enrolled1 locationNCT07202663
Recruiting

Preliminary Characterization of Commercial Kratom Extract Products

Kratom PharmacokineticsKratom Pharmacodynamics
Johns Hopkins University16 enrolled2 locationsNCT06640569
Recruiting

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

Kawasaki DiseaseRivaroxabanCoronary Artery Aneurysm+2 more
Children's Hospital of Fudan University60 enrolled1 locationNCT06993636
Recruiting
Phase 1

Vancomycin Dose Optimization in Obesity

Pharmacokinetics and Pharmacodynamics
University of Michigan24 enrolled1 locationNCT06601257
Recruiting
Phase 1

KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts

Pharmacodynamics
Mikko Niemi15 enrolled1 locationNCT06469450